M. Metra et al., Use of cardiopulmonary exercise testing with hemodynamic monitoring in theprognostic assessment of ambulatory patients with chronic heart failure, J AM COL C, 33(4), 1999, pp. 943-950
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES We studied whether direct assessment of the hemodynamic response
to exercise could improve the prognostic evaluation of patients with heart
failure (HF) and identify those in whom the main cause of the reduced func
tional capacity is related to extracardiac factors.
BACKGROUND Peak exercise oxygen consumption (VO2) is one of the main progno
stic variables in patients with HF, but it is influenced also by many extra
cardiac factors.
METHODS Bicycle cardiopulmonary exercise testing with hemodynamic monitorin
g was performed, in addition to clinical evaluation and radionuclide ventri
culography, in 219 consecutive patients with chronic HF (left ventricular e
jection fraction, 22 +/- 7%; peak VO2, 14.2 +/- 4.4 ml/kg/min).
RESULTS During a follow-up of 19 +/- 25 months, 32 patients died and 6 unde
rwent urgent transplantation with a 71% cumulative major event-free a-year
survival. Peak exercise stroke work index (SWI) was the most powerful progn
ostic variable selected by Cox multivariate analysis, followed by serum sod
ium and left ventricular ejection fraction, for one-year survival, and peak
VO2 and serum sodium for two-year survival. Two-year survival was 54% in t
he patients with peak exercise SWI less than or equal to 30 g m/m(2) versus
91% in those with a SWI >30 g.m/m(2) (p < 0.0001). A significant percentag
e of patients (41%) had a normal cardiac output response to exercise with a
n excellent two-year survival (87% vs. 58% in the others) despite a relativ
ely low peak VO2 (15.1 +/- 4.7 ml/kg/min).
CONCLUSIONS Direct assessment of exercise hemodynamics in patients with HF
provides additive independent prognostic information, compared to tradition
al noninvasive data. (J Am Coil Cardiol 1999;33:943-50) (C) 1999 by the Ame
rican College of Cardiology.